Campenet, S., Lamarre, M., Durand, J., Perez, V., Peixoto, P., Delage-Mourroux, R., Guittaut, M., Baguet, A., & Despouy, G. (28 March 2026). GABARAPL1 is important for the activation of HRI during eIF2α phosphorylation-dependent stress response to sodium arsenite. Scientific Reports, 16 (1). doi:10.1038/s41598-026-44621-2 |
Overs, A., Molimard, C., Durand, J., Bibeau, F., Arnould, L., Monnien, F., Clavier, C., Borg, C., Guittaut, M., Feugeas, J.-P., Hervouet, E., Peixoto, P., & Selmani, Z. (25 November 2025). Dynamic DNA methylation changes during colorectal oncogenesis with insights from adenoma stages. Scientific Reports, 15 (1), 45283. doi:10.1038/s41598-025-28656-5 |
Mercier, C., Durand, J., Fraichard, A., Perez, V., Hervouet, E., Peixoto, P., Delage-Mourroux, R., Guittaut, M., & Baguet, A. (02 February 2025). Chemical inhibition of eIF4A3 abolishes UPF1 recruitment onto mRNA encoding NMD factors and restores their expression. Biochemical and Biophysical Research Communications, 747, 151270. doi:10.1016/j.bbrc.2024.151270 |
Overs, A., Peixoto, P., Hervouet, E., Molimard, C., Monnien, F., Durand, J., Guittaut, M., Vienot, A., Viot, J., Herfs, M., Borg, C., Feugeas, J.-P., & Selmani, Z. (18 October 2024). COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR. Clinical Epigenetics, 16 (1), 146. doi:10.1186/s13148-024-01748-1 |